arrow
S

Sharon Hassin-Baer

Tel Aviv University
H指数:44
被引数:8,042

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LRRK2 rare-variant per-domain genetic burden in Parkinson's Disease: association confined to the kinase domain

LRRK2罕见变异各结构域遗传负担在帕金森病中的关联:局限于激酶结构域

2025-04-290
OA
Is the Subthalamic Nucleus Sleeping Under Nitrous Oxide-Ketamine General Anesthesia?

丘脑底核在笑气-氯胺酮全身麻醉下是否处于睡眠状态?

2025-03-050
OAAI
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons (vol 19, 88, 2024)
2024-12-180
OAAI
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

帕金森氏病风险基因组织蛋白酶B促进多巴胺能神经元中纤维状 α-突触核蛋白清除,溶酶体功能和葡糖脑苷脂酶活性

2024-11-251
PRE
A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease

一种用于帕金森病皮肤 α-突触核蛋白检测的新型超分辨率显微镜平台

2024-09-040
OAAI
The yield of genetic workup for middle-aged and elderly patients with neurological disorders in a real-world setting
2024-08-010
PRE
Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies

患有脑膜黄瘤病 (CTX) 的妇女在怀孕期间的鹅去氧胆酸 (CDCA) 治疗: 从19次怀孕中吸取的经验教训

2024-05-011
OAAI
Association of Rare Variants in ARSA with Parkinson's Disease
2023-06-283
OAAI
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease
BRAIN
IF11.7
2022-11-1110
OAAI